Our attorneys are currently investigating a potential class action against the makers of Relaxium concerning the marketing of this dietary supplement.
Relaxium is marketed as an all natural dietary supplement allegedly clinically proven to reduce the symptoms of anxiety including restlessness, fatigue, sleeplessness, inability to concentrate, headache and heart palpitations. In an attempt to lend credibility to its marketing claims, Relaxium is marketed as being “endorsed by: American Behavioral Research Institute”.
The American Behavioral Research Institute, however, appears to be a company established by the developer of Relaxium, Eric Ciliberti, and not an objective, independent third party. In fact, the trademark for Relaxium is owned by the American Behavioral Research Institute which, in turn, is owned by Ciliberti.
If you purchased Relaxium, you may have been a victim of unfair and deceptive marketing claims. Please contact us, if you would like to discuss your legal options.